SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,645,275,411 |
| Positions | 31 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| NEOGENOMICS INC | NEO | Common Stocks | $179,158,241 | 12,279,523 |
| SI-BONE INC | SIBN | Common Stocks | $132,648,715 | 8,127,985 |
| AXOGEN INC | AXGN | Common Stocks | $126,946,795 | 2,748,361 |
| APOGEE THERAPEUTICS INC | APGE | Common Stocks | $123,477,259 | 930,289 |
| PALVELLA THERAPEUTICS INC | PVLA | Common Stocks | $117,961,911 | 771,901 |
| TWIST BIOSCIENCE CORPORATION | TWST | Common Stocks | $74,889,747 | 727,933 |
| ENLIVEN THERAPEUTICS INC | ELVN | Common Stocks | $69,058,063 | 1,360,750 |
| GUARDANT HEALTH | GH | Common Stocks | $66,251,148 | 441,586 |
| 908 DEVICES INC | MASS | Common Stocks | $54,660,395 | 6,282,804 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Common Stocks | $54,297,678 | 3,023,256 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.